DuPont de Nemours has delivered a strong run over the past few years, and the question now is whether the current US$153.46 share price lines up with the cash the business is expected to generate. With attention on both operational progress and sustainability commitments, the stock invites a closer look at what its cash flows really support.
The stock's next move may depend on whether that recent share price strength is justified by DuPont de Nemours' underlying cash flows and the intrinsic value suggested by a Discounted Cash Flow (DCF) view.
If you are weighing whether DuPont de Nemours' US$153.46 price is fully backed by its cash flows, it can help to compare that question across 35 high quality undervalued stocks.
The Discounted Cash Flow (DCF) approach here uses DuPont de Nemours' future free cash flows and discounts them back to today. On the latest twelve month view the group generated about $866.3 million of free cash flow, and the model then assumes that this cash base grows rather than shrinks over time, with projected free cash flows climbing through the next decade.
Growth in those projections is not explosive, yet the DCF output still places DuPont de Nemours' estimated intrinsic worth substantially above the current US$153.46 share price. Because DuPont's third quarter 2026 update highlighted strong free cash flow conversion and ongoing share buybacks, the market reaction so far leaves a gap between what the cash flow model suggests and where the stock currently trades. Find out what DuPont de Nemours could be worth using our Discounted Cash Flow (DCF) estimate.
Simply Wall St Narratives pick up where the DCF puzzle leaves off for DuPont de Nemours' stock by spelling out which future paths for growth, profitability and earnings would need to hold for the shares to be worth materially more or materially less than the current price. The analysis sets out the assumptions behind each fair value so you can line those up against the company’s reported numbers as they come through.
Community views on DuPont de Nemours pull in opposite directions, with one camp seeing more value in the reshaped portfolio and another focused on legal and cost headwinds.
Bull case: 8% undervalued
"Disciplined capital allocation that combines high free cash flow conversion near 100% with sizeable share repurchases, dividends and over US$1b of capacity for Healthcare and Water acquisitions provides multiple levers…"
Discover why this Narrative puts DuPont de Nemours at 8% undervalued.
Bear case: 6% overvalued
"Bearish analysts expect rising environmental compliance costs, PFAS-related cash settlements and weaker demand in some legacy end markets to keep DuPont de Nemours' profitability under pressure over time…"
Explore why this Narrative puts DuPont de Nemours at 6% overvalued.
Numbers tell part of the DuPont de Nemours story, but the people setting priorities and the way their rewards are structured can tilt outcomes in very different directions. See who runs DuPont de Nemours and how they are paid.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com